STERIS enters $1.1 billion revolving credit facility replacing its 2021 agreement
On October 7, 2024, STERIS and affiliated borrowers entered a $1.1 billion revolving credit agreement with JPMorgan Chase Bank as administrative agent, replacing the credit agreement dated March 19, 2021. The facility matures five years after October 7, 2024, and proceeds will fund general corporate purposes and working capital.
Key points
- Revolving facility of $1,100 million, expandable by up to $625 million at lenders' discretion
- Matures five years after October 7, 2024; interest is based on a base rate or relevant rate plus an applicable margin tied to STERIS's debt rating
- Contains customary covenants, including limits on leverage and a minimum interest coverage requirement
- Replaces the existing credit agreement dated March 19, 2021
The filing
Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 07, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.